MoneyWorks4Me

Ind-Swift informs about change in directorate

22 Sep 2022 Evaluate
Ind-Swift has informed that the shareholder in their 36th Annual General Meeting held on 21st September, 2022 have approved appointment of Bhupinder Singh as an Independent Director of the Company for term of five consecutive years, with effective from 23rd June, 2022.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..